Biomedical Materials

DescriptionPolymer used to make controlled release nanoparticles or scaffolds for biomedical applications.

DescriptionHeterobifunctional degradable PLGA for conjugation, grafting and functionalization for drug delivery applications.

DescriptionHeterobifunctional degradable PLGA for conjugation, grafting and functionalization for drug delivery applications.

Poly(D,L-lactide-co-glycolide)

Poly(D,L-lactide-co-glycolide)

DescriptionCharacteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) arein vivobiodegradability, tunable drug release profile and very high encapsulation capacity.PLGA polymers find uses in the production of biodegradable

DescriptionCharacteristic properties of ester terminated poly(D,L-lactide-co-glycolide) (PLGA) arein vivobiodegradability, tunable drug release profile and very high encapsulation capacity.PLGA polymers find uses in the production of biodegradable

Poly(D,L-lactide-co-glycolide) acid terminated

DescriptionControlled release, nanoparticles, scaffolds.

DescriptionBiocompatible, amphiphilic block copolymer composed of a hydrophilic PEG block and a hydrophobic poly(D,L-lactide-co-glycolide) (PLGA) block. These materials have been used in control release and nanoparticle formulation for drug

DescriptionBiocompatible, amphiphilicblockcopolymer composed of a hydrophilic PEGblockand a hydrophobic Poly(lactide-co-glycolide) (PLGA)block, functionalized with a terminal carboxylic acid. These materials have been used in control release and

DescriptionThis poly(ether ester urethane) based on PLGA-PEG-PLGA triblock copolymers linked with a diisocyanate is a biodegradable, resorbable gel former for use in drug delivery systems. This polymer doesn′t rely on temperature or pH to induce